⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTL News
Artelo Biosciences, Inc. Common Stock
Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success
globenewswire.com
ARTL
Form 8-K
sec.gov
ARTL
Form 8-K
sec.gov
ARTL
Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results
globenewswire.com
ARTL
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development
globenewswire.com
ARTL
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
globenewswire.com
ARTL
Form 8-K
sec.gov
ARTL
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
globenewswire.com
ARTL
ArtemiLife Nears Milestone in Landmark Prostate Cancer Clinical Trial
prnewswire.com
ARTL
Form 8-K
sec.gov
ARTL